The Journal of Practical Medicine >
Effects of Sanqi on Sortilin, TLRs and vascular calcification in rats with chronic renal failure
Received date: 2023-04-19
Online published: 2024-04-08
Objective Taking Sortilin as the entry point, this study aims to explore the mechanism of vascular calcification in chronic renal failure (CRF) and explore the influence of Sanqi on Sortilin, TLRs and vascular calcification, and to provide an effective method for clinical reduction of cardiovascular events in CRF. Methods Thirty-six male SD rats were randomly divided into normal group, model group, low-, medium- and high-dose Sanqi group and calcitriol group, with 6 rats in each. The replicative CRF vascular calcification rat model was fed with adenine combined with high phosphorus diet. Aortic calcium salt deposition, serum creatinine (Scr), urea nitrogen (BUN), blood calcium (Ca), blood phosphorus (P), total cholesterol (TC), triglyceride (TG), TLRs and Sortilin protein in aorta and inflammatory factors were detected. Results In the model group, renal fibrosis was obvious and many adenine crystals were found in renal interstitium. Large deposits of calcium salts were found. Renal fibrosis and calcium salt deposition were alleviated in different degrees in all treatment groups. Compared with those in the normal group, the level of BUN, Cr, P, TG, TC, IFN-γ, IL-6, IL-10 and IL-17A in the serum of the model group was ascended (P < 0.01), while the level of Ca was descended (P < 0.01). Compared with those in the model group, the level of BUN, Cr, P, TG, TC, IFN-γ, IL-6, IL-10 and IL-17A in the serum of rats in the Sanqi medium and high dose group and calcitriol group was significantly decreased (P < 0.01), and the contents of Ca were significantly increased (P < 0.05 or P < 0.01). Compared with those in the normal group, the protein expression of BMP2, RUNX2, Sortilin, TLR7 and TLR9 in aortic tissue of rats in the model group was elevated (P < 0.01), while the protein expression of SM22α was declined (P < 0.01). Compared with those in the model group, the protein expression of BMP2, RUNX2, Sortilin, TLR7, and TLR9 in the low-, medium-, and high-dose Sanqi group and calcitriol group was decreased significantly (P < 0.01); the protein expression of SM22α was increased significantly (P < 0.05 or P < 0.01), and the high-dose Sanqi group and calcitriol group had more significant effects. Conclusion Sanqi can improve renal fibrosis and vascular calcification in CRF model rats, and its mechanism may be related to the regulation of biological functions of Sortilin and TLRs.
Key words: Sanqi; chronic renal failure; vascular calcification; sortilin; TLR7; TLR9
Zhimin HUANG , Liangxi LU , Yini JIANG , Xiaoyu LIU , Zhiying ZHANG , Jinyu WU . Effects of Sanqi on Sortilin, TLRs and vascular calcification in rats with chronic renal failure[J]. The Journal of Practical Medicine, 2024 , 40(6) : 773 -779 . DOI: 10.3969/j.issn.1006-5725.2024.06.008
| 1 | LI P K, GARCIA-GARCIA G, LUI S F, et al. Kidney Health for Everyone Everywhere-From prevention to detection and equitable access to care[J]. Nefrologia (Engl Ed),2020,40(2):133-141. doi:10.1016/j.nefro.2019.11.001 |
| 2 | DUSING P, ZIETZER A, GOODY P R, et al. Vascular pathologies in chronic kidney disease: pathophysiological mechanisms and novel therapeutic approaches[J]. J Mol Med (Berl),2021,99(3):335-348. doi:10.1007/s00109-021-02037-7 |
| 3 | FANG Y, GINSBERG C, SUGATANI T, et al. Early chronic kidney disease-mineral bone disorder stimulates vascular calcification[J]. Kidney Int,2014,85(1):142-150. doi:10.1038/ki.2013.271 |
| 4 | HIMMELSBACH A, CILIOX C, GOETTSCH C. Cardiovascular Calcification in Chronic Kidney Disease-Therapeutic Opportunities[J]. Toxins (Basel),2020,12(3): 181. doi:10.3390/toxins12030181 |
| 5 | SUN S, YANG J, XIE W, et al. Complicated trafficking behaviors involved in paradoxical regulation of sortilin in lipid metabolism[J]. J Cell Physiol,2020, 235(4):3258-3269. doi:10.1002/jcp.29292 |
| 6 | JANKOWSKI V, SARITAS T, KJOLBY M, et al.Carbamylated sortilin associates with cardiovascular calcification in patients with chronic kidney disease[J]. Kidney Int,2022,101(3):574-584. doi:10.1016/j.kint.2021.10.018 |
| 7 | YABE W T, MATSUBA S, TAKEDA K, et al. TLR Signals Posttranscriptionally Regulate the Cytokine Trafficking Mediator Sortilin[J]. Sci Rep,2016,6:26566. doi:10.1038/srep26566 |
| 8 | 蒲江,魏晓,龚财判,等. 腺嘌呤加高磷饮食快速建立慢性肾脏病血管钙化动物模型法[J]. 西南军医,2018,20(4):445-450. doi:10.3969/j.issn.1672-7193.2018.04.014 |
| 9 | RYSZ J, FRANCZYK B, ?AWINSKI J, et al. Oxidative stress in ESRD patients on dialysis and the risk of cardiovascular diseases [J]. Antioxidants (Basel), 2020, 9(11): 1079. doi:10.3390/antiox9111079 |
| 10 | LIU X X, CAO F Y, LIU S, et al. BMP2/Smad signaling pathway is involved in the inhibition function of fibroblast growth factor 21 on vascular calcification[J]. Biochem Biophys Res Commun, 2018, 503(2): 930-937. doi:10.1016/j.bbrc.2018.06.098 |
| 11 | 李海涛,林劲,韩丽珍,等. 神经调节蛋白1/转化生长因子β1对血管平滑肌细胞骨架的作用[J]. 实用医学杂志,2021,37(7):863-868. |
| 12 | WANG C, TANG Y, WANG Y M,et al. Label-free quantitative proteomics identifies Smarca4 is involved in vascular calcification [J]. Ren Fail,2019,41 (1) :220-228. doi:10.1080/0886022x.2019.1591997 |
| 13 | WEI R, ENAKA M, MURAGAKI Y. Activation of KEAP1/NRF2/P62 signaling alleviates high phosphateinduced calcification of vascular smooth muscle cells by suppressing reactive oxygen species production [J]. Sci Rep,2019,9(1) :10366. doi:10.1038/s41598-019-46824-2 |
| 14 | KURABAYASHI M. Molecular mechanism of vascular calcification[J]. Clin Calcium, 2019,29(2):157-163. |
| 15 | GIOVANNINI S, BISCETTI F, BRAU F, et al. Sortilin/Omentin-1 ratio in peripheral artery disease: a cross-sectional study on 295 unselected elderly patients[J]. Mech Ageing Dev,2022,205:111677. doi:10.1016/j.mad.2022.111677 |
| 16 | CHU X, LIU R, LI C, The association of plasma sortilin with essential hypertension and subclinical carotid atherosclerosis: A cross-sectional study[J]. Front Cardiovasc Med,2022,9:966890. doi:10.3389/fcvm.2022.966890 |
| 17 | CONLON D M, SCHNEIDER C V, KO Y A, et al. Sortilin restricts secretion of apolipoprotein B-100 by hepatocytes under stressed but not basal conditions[J]. J Clin Invest,2022,132(6):e144334. doi:10.1172/jci144334 |
| 18 | LOPEZ M R, GONZALEZ GAY M A. IL-6: linking chronic inflammation and vascular calcification[J].Nat Rev Rheumatol,2019,15 (8):457-459. doi:10.1038/s41584-019-0259-x |
| 19 | 康婷,陈波,欧三桃. 慢性肾脏病血管钙化大鼠血清炎症因子抗体芯片检测及分析[J]. 中国比较医学杂志,2019,29(1):9-15. doi:10.3969/j.issn.1671-7856.2019.01.002 |
| 20 | HENAUT L, MASSY Z A. New insights into the key role of interleukin 6 in vascular calcifification of chronic kidney disease[J]. Nephrol Dial Transpl,2018,33:543-548. doi:10.1093/ndt/gfx379 |
| 21 | ZICKLER D, LUECHT C, WILLY K, et al. Tumour necrosis factor-alpha in uraemic serum promotes osteoblastic transition and calcification of vascular smooth muscle cells via extracellular signal-regulated kinases and activator protein 1/cFOS-mediated induction of interleukin 6 expression[J]. Nephrol Dial Transplant,2018,33(4):574-585. doi:10.1093/ndt/gfx316 |
| 22 | FUKUDA D, NISHIMOTO S, AINI K, et al. Toll-like receptor 9 plays a pivotal role in angiotensin ii-induced atherosclerosis[J]. J Am Heart Assoc,2019,8(7):e010860. doi:10.1161/jaha.118.010860 |
| 23 | ZHAO Y, CAI Y, CUI L Y, et al. Suppression of Gut Bacterial Translocation Ameliorates Vascular Calcification through Inhibiting Toll-Like Receptor 9-Mediated BMP-2 Expression[J]. Oxid Med Cell Longev,2019:3415682. doi:10.1155/2019/3415682 |
| 24 | KARADIMOU G, FOLKERSEN L, BERG M, et al. Low TLR7 gene expression in atherosclerotic plaques is associated with major adverse cardio- and cerebrovascular events[J]. Cardiovasc Res,2017,113:30-39. doi:10.1093/cvr/cvw231 |
| 25 | KROGMANN A O, LUSEBRINK E, LAHRMANN C, et al. Toll-Like Receptor 7 Stimulation Promotes the Development of Atherosclerosis in Apolipoprotein E-Deficient Mice[J]. Int Heart J,2020,61(2):364-372. doi:10.1536/ihj.19-365 |
| 26 | LQBAL F, SCHLOTTER F, BECKER-GREENE D, et al. Sortilin enhances fibrosis and calcification in aortic valve disease by inducing interstitial cell heterogeneity[J]. Eur Heart J,2023,44(10):885-898. doi:10.1093/eurheartj/ehac818 |
/
| 〈 |
|
〉 |